Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bardou

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
British Journal of Pharmacology|February 11, 2004
The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulationC Rouget, M Breuiller-Fouché, F J Mercier, et al.
Cell Death & Disease|April 15, 2016
Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapyV Clausse, A R Goloudina, B Uyanik, et al.
British Journal of Pharmacology|August 22, 2000
Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometriumM Bardou, C Loustalot, J Cortijo, et al.
Biology of Reproduction|September 24, 2005
Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsiaC Rouget, O Barthez, F Goirand, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm studyM Luu, P Vabres, H Devilliers, et al.
European Journal of Medical Genetics|August 31, 2018
Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literatureJ Delanne, S Nambot, A Chassagne, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
British Journal of Pharmacology|February 11, 2004
The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulationC Rouget, M Breuiller-Fouché, F J Mercier, et al.
Cell Death & Disease|April 15, 2016
Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapyV Clausse, A R Goloudina, B Uyanik, et al.
British Journal of Pharmacology|August 22, 2000
Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometriumM Bardou, C Loustalot, J Cortijo, et al.
Biology of Reproduction|September 24, 2005
Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsiaC Rouget, O Barthez, F Goirand, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm studyM Luu, P Vabres, H Devilliers, et al.
European Journal of Medical Genetics|August 31, 2018
Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literatureJ Delanne, S Nambot, A Chassagne, et al.
Pageof 4